Articles dans des revues avec comité de lecture (50)
36.
Devosse, T., Dutoit, R., Migeotte, I., De Nadai, P., Imbault, V., Communi, D., Salmon, I., & Parmentier, M. (2011). Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3. The Journal of immunology, 187(3), 1475-1485. doi:10.4049/jimmunol.100354538.
Dubielecka, P. M., Ladwein, K. I., Xiong, X., Migeotte, I., Chorzalska, A., Anderson, K. V., Sawicki, J., Rottner, K., Stradal, T., & Kotula, L. (2011). Essential role for Abi1 in embryonic survival and WAVE2 complex integrity. Proceedings of the National Academy of Sciences of the United States of America, 108(17), 7022-7027. doi:10.1073/pnas.101681110841.
Gao, J.-L., Guillabert, A., Hu, J., Le, Y., Urizar Andrieu, E., Seligman, E., Fang, K. J., Yuan, X., Imbault, V., Communi, D., Wang, J. M., Parmentier, M., Murphy, P. M., & Migeotte, I. (2007). F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor. The Journal of immunology, 178(3), 1450-1456.43.
Migeotte, I., Riboldi, E., Franssen, J.-D., Grégoire, F., Loison, C., Wittamer, V., Detheux, M., Robberecht, P., Costagliola, S., Vassart, G., Sozzani, S., Parmentier, M., & Communi, D. (2005). Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. The Journal of Experimental Medicine, 201(1), 83-93. doi:10.1084/jem.2004127744.
Wittamer, V., Franssen, J.-D., Vulcano, M., Mirjolet, J.-F., Le Poul, E., Migeotte, I., Brezillion, S., Tyldesley, R., Blanpain, C., Detheux, M., Mantovani, A., Sozzani, S., Vassart, G., Parmentier, M., & Communi, D. (2003). Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. The Journal of Experimental Medicine, 198(7), 977-985. doi:10.1084/jem.2003038245.
Migeotte, I., Franssen, J.-D., Goriely, S., Willems, F., & Parmentier, M. (2002). Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations. European Journal of Immunology, 32(2), 494-501. doi:10.1002/1521-4141(200202)32:2<494::AID-IMMU494>3.0.CO;2-Y46.
Blanpain, C., Doranz, B. J., Vakili, J., Rucker, J., Govaerts, C., Baik, S. S., Lorthioir, O., Migeotte, I., Libert, F., Baleux, F., Vassart, G., Doms, R. W., & Parmentier, M. (1999). Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. The Journal of biological chemistry, 274(49), 34719-34727. doi:10.1074/jbc.274.49.3471947.
Costagliola, S., Sunthorntepvarakul, T., Migeotte, I., Van Sande, J., Kajava, A. M., Refetoff, S., & Vassart, G. (1999). Structure-function relationships of two loss-of-function mutations of the thyrotropin receptor gene. Thyroid, 9(10), 995-1000.